We found a significant difference between groups in factor II (P = 0.023) and factor X (P = 0.008) levels over time.
We analyzed the median overall scores for strabismus patients, normal adults and patients with other eye diseases to test discriminative validity and found a significant difference between groups.
However, we found a significant difference between groups (Z = -2.3, P < 0.02) on BDI scores when comparing patients with white matter lesions (Median BDI score = 6) and patients without (Median BDI score = 8.7).
PAI-1 and t-PA had also found a significant difference between groups, PAI-1 (time of clamp release, 24 hours, and 3 days, p = 0.002, 0.03, and 0.03, resp).
Post-hoc analysis of the dose of therapy found a significant difference between groups in both the number of hours of therapy and the numbers of hours HP time.
Under double-blind conditions, we found a significant difference between groups for the total symptom score (z = −4.917, p < 0.001) and total number of symptoms reported (z = −5.282, p < 0.001), with sensitives reporting greater symptom severity (mean ± SE = 5.23 ± 1.06, n = 48) and number of symptoms (4.03 ± 0.71, n = 48) compared with controls (1.20 ± 0.18 and 0.92 ± 0.10, respectively; n = 132).
